+ Part of the HMP Communications
Cardiovascular Network
Women With Heart Attack More Likely Than Men To Present Without Chest Pain and Have Higher In-Hospital Mortality
CHICAGO – Among heart attack patients, women are more likely than men to present to a hospital without chest pain and also have a higher rate of in-hospital death following a heart attack than men within the same age group, although these differences decrease with increasing age, according to a study in the February 22/29 issue of JAMA.
Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
MINNEAPOLIS –– February 17, 2012 — Medtronic Inc. today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity™ Drug-Eluting Stent (DES) for the treatment of coronary artery disease (CAD).
HHS Announces Intent to Delay ICD-10 Compliance Date
As part of President Obama’s commitment to reducing regulatory burden, Health and Human Services Secretary Kathleen G. Sebelius today announced that HHS will initiate a process to postpone the date by which certain health care entities have to comply with International Classification of Diseases, 10th Edition diagnosis and procedure codes (ICD-10).
St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia
Country-specific analysis will evaluate the cost effectiveness of an FFR-guided intervention strategy for patients with multivessel coronary artery disease in Japan, China, India, Korea, and Australia
Siemens 3-D Angiography Imaging Software to Guide TAVR Cleared by FDA
New Processing Software Simplifies Workflow for Minimally Invasive Heart Valve Implantation
CATCH-UP 2012: Heart Failure, Devices, and Interventions
PCR Focus Group on Bioresorbable Vascular Scaffolds
Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive™ System
ST. LOUIS, Feb. 8, 2012 -- Stereotaxis, Inc. announced that its Vdrive™ Robotic Navigation System, which provides physicians the ability to remotely manipulate traditionally non-robotic catheters, is expected to surpass 500 clinical procedures in Europe in February.
Medtronic Stent Resulted in 90% Freedom From Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
New Clinical Data Presented for First Time at Medical Meetings in U.S. and Europe
Show Durable Vessel Patency in Treating Atherosclerotic Lesions of Superficial Femoral Artery
Goal of Robotic-Assisted PCI procedures is to reduce radiation exposure / Demonstration at CRT
NATICK, Mass.
ACCF/AATS/SCAI/STS Release Critical Consensus Document to Help Guide Use of New Minimally Invasive Heart Therapy to Treat Aortic Stenosis
JANUARY 31, 2012 — With the U.S.
Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk of Bleeding, Death
NEW ORLEANS, Feb. 3, 2012 -- The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
New Appropriate Use Criteria Reflect Latest Scientific Data on Restoring Blood Flow to Heart
Appropriate use criteria will help physicians select treatments for patients
Volume 24 - Issue 2 - February 2012
Use of Iodinated Contrast Media in Imaging Procedures Appears to Affect Thyroid Function
CHICAGO – Exposure to iodinated contrast media (ICM) during imaging procedures is associated with changes in thyroid function, and increased risk of developing hyperthyroidism, according to a report in the January 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Circulation: Sexual Activity is Safe for Most Heart, Stroke Patients
DALLAS, Jan. 19, 2012 -- If you have stable cardiovascular disease, it is more than likely that you can safely engage in sexual activity, according to an American Heart Association scientific statement.
Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections
January 19, 2012 – W. L. Gore & Associates, Inc. (Gore) announced that the US Food and Drug Administration (FDA) has approved the Conformable Gore® Tag® Thoracic Endoprosthesis for endovascular repair of isolated lesions of the descending thoracic aorta, including traumatic aortic transections.
Independent Data Safety Monitoring Board Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
"This is further evidence that FFR should be considered the standard of care for patients with coronary artery disease"
Philips Begins Clinical Trial Enrollment for CHILL-MI Study
Study will further evaluate the safety and effectiveness of endovascular cooling to reduce reperfusion injury in acute ST-elevation myocardial infarction patients